carbamazepine has been researched along with dynorphins in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gebhart, GF; Joshi, SK; Kardos, S; Su, X | 1 |
1 other study(ies) available for carbamazepine and dynorphins
Article | Year |
---|---|
Sodium channel blocking actions of the kappa-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Anti-Arrhythmia Agents; Carbamazepine; Dynorphins; Male; Membrane Potentials; Mexiletine; Neurons, Afferent; Nociceptors; Pelvis; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Sodium Channel Blockers; Stereoisomerism | 2002 |